<DOC>
	<DOCNO>NCT01896544</DOCNO>
	<brief_summary>Sepsis clinical entity occur patient serious infection . Though severity illness may vary , every year , approximately 1.6 million Americans treated sepsis . Even timely intervention , anywhere 16 % &gt; 80 % patient sepsis survive . Immune dysfunction think play critical role ability infection evolve sepsis eventually lead death . Recently , vitamin D identify key regulator immune system . While remains unclear whether optimize vitamin D status may improve outcome sepsis , little known effect vitamin D supplementation patient severe infection . As , goal study whether high dos cholecalciferol ( vitamin D3 ) improve vitamin D status boost certain aspect immune system patient sepsis .</brief_summary>
	<brief_title>Cholecalciferol Supplementation Sepsis ICU</brief_title>
	<detailed_description>Sepsis clinical syndrome complicates severe infection . It characterize cardinal sign inflammation ( e.g . vasodilation , leukocytosis , increase microvascular permeability ) occur tissue remote site infection . Current theory onset progression sepsis syndrome focus dysregulation inflammatory response , include possibility massive uncontrolled release pro-inflammatory mediator initiate chain event lead widespread tissue injury . The degree immune dysfunction think correlate severity sepsis syndrome . Sepsis syndrome range sepsis , severe sepsis , septic shock , multiple organ dysfunction syndrome ( MODS ) . The mortality associate estimate 16 % , 20 % , 46 % , &gt; 80 % , respectively . The annual incidence sepsis syndrome exceeds 1.6 million case United States alone . Recently , cell innate adaptive immune system show express vitamin D receptor . Vitamin D appear necessary interferon-γ dependent T cell response infection . In low vitamin D state , dysfunctional macrophage activity become evident . Vitamin D also important link Toll Like Receptor ( TLR ) activation antibacterial response . Human macrophages stimulate TLR induce : 1 ) vitamin D receptor expression ; 2 ) conversion 25 ( OH ) D biologically active form 1,25-dihydroxyvitamin D ; 3 ) production cathelicidin ( LL-37 ) , endogenous antimicrobial peptide potent activity bacteria , virus , fungi , mycobacteria . LL-37 highly express plasma natural barrier site ( e.g . skin , gut , lung ) may represent important first-line defense innate immune system . In human , cholecalciferol ( vitamin D3 ) either obtain diet synthesized skin upon exposure ultraviolet B ( UVB ) radiation . Cholecalciferol convert 25 ( OH ) D liver cell immune system . Serum 25 ( OH ) D measure relative ease abundant vitamin D metabolite . It therefore , often use proxy total body vitamin D status 25 ( OH ) D level &lt; 30 ng/mL characterize insufficient state . A grow body evidence suggest significant proportion ( 50-90 % ) critically ill patient may insufficient 25 ( OH ) D level admission intensive care unit ( ICU ) . 25 ( OH ) D insufficiency , turn , appear associate high risk mortality critically ill patient . However , randomize , placebo-controlled trial ( RCTs ) aim study effect vitamin D supplementation critical illness limit largely focused superficial assessment vitamin D status . While know septic patient nearly universally low 25 ( OH ) D level vitamin D level inversely correlate severity sepsis , little known regard effect vitamin supplementation patient cohort . Therefore , goal determine whether vitamin D supplementation patient highly suspected sepsis syndrome may effective optimize 25 ( OH ) D level improve host production antimicrobial polypeptide LL-37 .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Avitaminosis</mesh_term>
	<mesh_term>Rickets</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>English Spanish speaking Within 24 hour suspect diagnosis sepsis Meeting criterion sepsis ( define suspect confirmed infection AND least one diagnostic criterion follow grouping ) : 1 . Vital sign : 1 . Temperature : &gt; 38.3 Celsius ( C ) &lt; 36 Celsius ( C ) 2 . Heart rat e : &gt; 90/min , &gt; 2 standard deviation normal 3 . Tachypnea ( &gt; 20 breath per minute ) 4 . Altered mental status 5 . Positive fluid balance ( &gt; 20 mL/Kg 24 hr ) 6 . Glucose &gt; 140 mg/dL absence diabetes mellitus 2 . Inflammatory marker : 1. white blood cell ( WBC ) : &gt; 12,000 &lt; 4,000 2 . Normal WBC count &gt; 10 % immature form 3. creactive protein ( CRP ) &gt; 2 standard deviation normal value 4 . Pro‐ calcitonin &gt; 2 standard deviation normal value 3 . Hemodynamic 1 . Systolic blood pressure ( SBP ) &lt; 90 millimeter mercury ( mmHg ) , Mean Arterial Pressure ( MAP ) &lt; 70mmHg SBP decrease &gt; 40mmHg 2 . Vasopressor therapy maintain MAP &gt; 65mmHg 4 . Organ dysfunction 1 . Arterial hypoxemia arterial oxygen partial pressure/fractional inspire oxygen ( PaO2/FiO2 ) &lt; 300 2 . Acute Oliguria ( UoP &lt; 0.5 mL/Kg/hr least 2 hour ) 3 . Cr increase &gt; 0.5 mg/dL 4 . Coagulopathy : international normalize ratio ( INR ) &gt; 1.5 apartial prothrombin time ( aPTT ) &gt; 60 sec 5 . Thrombocytopenia : Platelet ( PLT ) &lt; 100 thousand ( K ) 6 . Hyperbilirubinemia : Total Bilirubin ( Tbili ) &gt; 4 mg/dL 5 . Tissue perfusion 1 . Lactate &gt; 2 mmol/L 2 . Decrease cap refill mottle Pregnant female immediate postpartum status `` Comfort measure '' status Inability provide inform consent surrogate consent History renal stone within past year History hypercalcemia within past year Baseline serum total calcium &gt; 10 mg/dL Established diagnosis associate increase risk hypercalcemia ( e.g . metastatic cancer , sarcoidosis , multiple myeloma , primary hyperparathyroidism ) History severe anemia ( Hematocrit &lt; 25 % ) Medications affect vitamin D metabolism ( e.g . antiepileptic , tuberculosis medication Already enrol plan enroll research study would conflict full participation current study confound observation interpretation study finding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>cholecalciferol</keyword>
	<keyword>vitamin D</keyword>
	<keyword>sepsis</keyword>
	<keyword>infection</keyword>
</DOC>